Torno Capital, LLC Bei Gene, Ltd. Call Options Transaction History
Torno Capital, LLC
- $1.56 Trillion
- Q1 2024
Call Options
2 transactions
Others Institutions Holding BGNE
# of Institutions
213Shares Held
45.1MCall Options Held
76.5KPut Options Held
72.3K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.72 Billion20.93% of portfolio
-
Capital International Investors Los Angeles, CA7.06MShares$1.15 Billion0.23% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$841 Million17.98% of portfolio
-
Primecap Management CO Pasadena, CA5MShares$813 Million0.59% of portfolio
-
Baillie Gifford & CO3.68MShares$598 Million0.42% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $16.9B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...